A Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection

Clinical trial NCT05265286 · COMPLETED

Trial details

NCT number: NCT05265286
Sponsor: Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Hemophilia A

Start date: 2022-04-14
Primary completion: 2022-08-21
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.